C Wojcik

Summary

Affiliation: Medical University of Warsaw
Country: Poland

Publications

  1. ncbi Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells
    C Wojcik
    Department of Pharmacology, Mount Sinai School of Medicine, New York, NY, USA
    Eur J Cell Biol 77:151-60. 1998
  2. ncbi Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells
    C Wojcik
    Department of Pharmacology, Mount Sinai School of Medicine, New York, NY, USA
    Neurochem Int 34:131-6. 1999
  3. ncbi Proteasome activator subunit PA28 alpha and related Ki antigen (PA28 gamma) are absent from the nuclear fraction purified by sucrose gradient centrifugation
    C Wojcik
    Department of Histology and Embryology, Warsaw Medical Academy, Poland
    Int J Biochem Cell Biol 31:273-6. 1999
  4. ncbi Proteasomes in human spermatozoa
    C Wojcik
    Department of Histology and Embryology, Biostructure Centre, Warsaw Medical Academy, ul Chalubinskiego 5, 02 004 Warsaw, Poland
    Int J Androl 23:169-77. 2000
  5. ncbi Lovastatin and simvastatin are modulators of the proteasome
    C Wojcik
    Department of Histology and Embryology, Biostructure Center, Warsaw Medical Academy, ul Chalubinskiego 5, 02 004 Warsaw, Poland
    Int J Biochem Cell Biol 32:957-65. 2000
  6. ncbi Proteasomes in apoptosis: villains or guardians?
    C Wojcik
    Department of Histology and Embryology, Institute of Biostructure, Medical University of Warsaw, Warszawa, Poland
    Cell Mol Life Sci 56:908-17. 1999
  7. ncbi Regulation of apoptosis by the ubiquitin and proteasome pathway
    Cezary Wojcik
    Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Warsaw, Poland
    J Cell Mol Med 6:25-48. 2002
  8. ncbi Ubiquitin--more than just a signal for protein degradation
    C Wojcik
    Medical University of Warsaw, Poland
    Trends Cell Biol 11:397-9. 2001
  9. ncbi Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice
    J Golab
    Department of Immunology, Medical University of Warsaw, Poland
    Anticancer Res 20:1717-21. 2000
  10. ncbi Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells
    L P Biały
    Department of Histology and Embryology, Center of Biostructure Research, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 40:135-6. 2002

Collaborators

Detail Information

Publications16

  1. ncbi Proteasome activator (PA28) subunits, alpha, beta and gamma (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells
    C Wojcik
    Department of Pharmacology, Mount Sinai School of Medicine, New York, NY, USA
    Eur J Cell Biol 77:151-60. 1998
    ..PA28gamma complexed with the proteasome may serve a function other than or in addition to activation and may also have a proteasome-independent function...
  2. ncbi Changes in proteasome expression and activity during differentiation of neuronal precursor NTera 2 clone D1 cells
    C Wojcik
    Department of Pharmacology, Mount Sinai School of Medicine, New York, NY, USA
    Neurochem Int 34:131-6. 1999
    ..Changes in proteasome activity and composition may contribute to the processes leading to differentiation of human neurons in vitro and to the properties of fully differentiated neurons...
  3. ncbi Proteasome activator subunit PA28 alpha and related Ki antigen (PA28 gamma) are absent from the nuclear fraction purified by sucrose gradient centrifugation
    C Wojcik
    Department of Histology and Embryology, Warsaw Medical Academy, Poland
    Int J Biochem Cell Biol 31:273-6. 1999
    ..This indicates, that only a small fraction of the PA28 activator is present in the nuclei as detected by immunofluorescence or/and it is easily removed during nuclear purification...
  4. ncbi Proteasomes in human spermatozoa
    C Wojcik
    Department of Histology and Embryology, Biostructure Centre, Warsaw Medical Academy, ul Chalubinskiego 5, 02 004 Warsaw, Poland
    Int J Androl 23:169-77. 2000
    ....
  5. ncbi Lovastatin and simvastatin are modulators of the proteasome
    C Wojcik
    Department of Histology and Embryology, Biostructure Center, Warsaw Medical Academy, ul Chalubinskiego 5, 02 004 Warsaw, Poland
    Int J Biochem Cell Biol 32:957-65. 2000
    ....
  6. ncbi Proteasomes in apoptosis: villains or guardians?
    C Wojcik
    Department of Histology and Embryology, Institute of Biostructure, Medical University of Warsaw, Warszawa, Poland
    Cell Mol Life Sci 56:908-17. 1999
    ....
  7. ncbi Regulation of apoptosis by the ubiquitin and proteasome pathway
    Cezary Wojcik
    Department of Histology and Embryology, Center of Biostructure Research, Medical University of Warsaw, Warsaw, Poland
    J Cell Mol Med 6:25-48. 2002
    ....
  8. ncbi Ubiquitin--more than just a signal for protein degradation
    C Wojcik
    Medical University of Warsaw, Poland
    Trends Cell Biol 11:397-9. 2001
  9. ncbi Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice
    J Golab
    Department of Immunology, Medical University of Warsaw, Poland
    Anticancer Res 20:1717-21. 2000
    ..Similarly, the influence of these drugs on tumor induced angiogenesis does not seem to explain the observed antitumor effects. Further studies are necessary to explain the striking antitumor effects of the PSI and TNF combination...
  10. ncbi Effects of the combination of a proteasome inhibitor (PSI) and an inhibitor of ubiquitin-ligases (Leu-Ala) on the ultrastructure of human leukemic U937 cells
    L P Biały
    Department of Histology and Embryology, Center of Biostructure Research, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 40:135-6. 2002
    ....
  11. ncbi Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in human promonocytic leukemic U937 cells
    I Młynarczuk
    Department of Immunology, Medical University of Warsaw, 5 Chałubinskiego Str, PL 02 004 Warsaw, Poland
    Anticancer Res 21:1237-40. 2001
    ..TRAIL/PSI did not affect the level of mRNA expression for TRAIL receptors (DR4, DR5, DcR1) and other apoptosis signal transduction molecules (TRADD, caspase-8)...
  12. ncbi Localization of a proteasomal antigen in human spermatozoa: immunohistochemical electron microscopic study
    L P Biały
    Department of Histology and Embryology, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 39:129-30. 2001
    ..The nuclear vacuoles with looser chromatin were usually strongly labeled. The nuclei of cells representing different stages of spermatogenesis, that were present in semen samples, were also labeled...
  13. ncbi Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines
    E Pleban
    Department of Histology and Embryology, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 39:133-4. 2001
    ..Non-transformed cell lines showed no sensitivity to PSI, as there was no difference in cell viability in comparison with the control group even after 72 h incubation...
  14. ncbi Proteasome localization and ultrastructure of spermatozoa from patients with varicocele--immunoelectron microscopic study
    H Ziemba
    Department of Histology and Embryology, Center of Biostructure Research, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 40:169-70. 2002
    ..The association of proteasomes with sperm chromatin and large residual bodies can be the sign of abnormality and disturbances in spermatogenesis associated with varicocele...
  15. ncbi Increased local vascular endothelial growth factor expression associated with antitumor activity of proteasome inhibitor
    T Stokłosa
    Department of Immunology, Center of Biostructure, Medical University of Warsaw, Warsaw, Poland
    Apoptosis 9:193-204. 2004
    ..We demonstrated that in C-26 colon adenocarcionoma higher VEGF production may render endothelial cells susceptible to the proapoptotic activity of PSI and is associated with inhibition of tumor growth...
  16. ncbi Effects of an inhibitor of tripeptidyl peptidase II (Ala-Ala-Phe-chloromethylketone) and its combination with an inhibitor of the chymotrypsin-like activity of the proteasome (PSI) on apoptosis, cell cycle and proteasome activity in U937 cells
    M Bury
    Department of Histology and Embryology, Medical Academy, Warsaw, Poland
    Folia Histochem Cytobiol 39:131-2. 2001
    ..This suggests that TPP II is possibly less important for cell metabolism than it was previously believed and it is less probable that it can be able to fully compensate for the loss of the proteasome function...